Drug derived from red wine may combat obesity, study says

11/5/2008 | BBC

Sirtris Pharmaceuticals' drug candidate SRT1720 partially prevented weight gain in mice on a high-fat diet when given at low dosage, and it completely prevented weight gain when given in high doses over 10 weeks, French researchers reported. The treatment, which is derived from the red-wine extract resveratrol, also raised blood-sugar tolerance and insulin sensitivity, according to the study.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC